Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 298

1.

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma.

Krimphove MJ, Tully KH, Friedlander DF, Marchese M, Ravi P, Lipsitz SR, Kilbridge KL, Kibel AS, Kluth LA, Ott PA, Choueiri TK, Trinh QD.

J Immunother Cancer. 2019 Nov 7;7(1):289. doi: 10.1186/s40425-019-0782-y.

2.

The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.

Fletcher SA, Cole AP, Lu C, Marchese M, Krimphove MJ, Friedlander DF, Mossanen M, Kilbridge KL, Kibel AS, Trinh QD.

Cancer. 2019 Oct 18. doi: 10.1002/cncr.32562. [Epub ahead of print]

PMID:
31626340
3.

Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.

Tully KH, Nguyen DD, Herzog P, Jin G, Noldus J, Nguyen PL, Kibel AS, Sun M, McGregor B, Basaria S, Trinh QD.

Eur Urol Oncol. 2019 Oct 14. pii: S2588-9311(19)30129-4. doi: 10.1016/j.euo.2019.08.003. [Epub ahead of print]

PMID:
31624049
4.

Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy.

Tully KH, Krimphove MJ, Reese SW, Kibel AS, Noldus J, Krasnow RE, Trinh QD, Sonpavde GP, Chang SL, Mossanen M.

Urology. 2019 Oct 3. pii: S0090-4295(19)30864-7. doi: 10.1016/j.urology.2019.09.029. [Epub ahead of print]

PMID:
31586570
5.

Predictors of Recurrence, Progression-Free and Overall Survival Following Open Versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Follow-Up.

Venkatramani V, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Soodana-Prakash N, Becerra MF, Swain S, Kendrick K, Smith JA Jr, Thompson IM, Parekh DJ.

J Urol. 2019 Sep 24:101097JU0000000000000565. doi: 10.1097/JU.0000000000000565. [Epub ahead of print]

PMID:
31549935
6.

Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, Aldrich MC, Andrew AS, Andrulis IL, Anton-Culver H, Antoniou AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Batra J, Beckmann MW, Benitez J, Benlloch S, Berchuck A, Berndt SI, Bickeböller H, Bien SA, Blomqvist C, Boccia S, Bogdanova NV, Bojesen SE, Bolla MK, Brauch H, Brenner H, Brenton JD, Brook MN, Brunet J, Brunnström H, Buchanan DD, Burwinkel B, Butzow R, Cadoni G, Caldés T, Caligo MA, Campbell I, Campbell PT, Cancel-Tassin G, Cannon-Albright L, Campa D, Caporaso N, Carvalho AL, Chan AT, Chang-Claude J, Chanock SJ, Chen C, Christiani DC, Claes KBM, Claessens F, Clements J, Collée JM, Correa MC, Couch FJ, Cox A, Cunningham JM, Cybulski C, Czene K, Daly MB, deFazio A, Devilee P, Diez O, Gago-Dominguez M, Donovan JL, Dörk T, Duell EJ, Dunning AM, Dwek M, Eccles DM, Edlund CK, Edwards DRV, Ellberg C, Evans DG, Fasching PA, Ferris RL, Liloglou T, Figueiredo JC, Fletcher O, Fortner RT, Fostira F, Franceschi S, Friedman E, Gallinger SJ, Ganz PA, Garber J, García-Sáenz JA, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, Goode EL, Goodman MT, Goodman G, Grankvist K, Greene MH, Gronberg H, Gronwald J, Guénel P, Håkansson N, Hall P, Hamann U, Hamdy FC, Hamilton RJ, Hampe J, Haugen A, Heitz F, Herrero R, Hillemanns P, Hoffmeister M, Høgdall E, Hong YC, Hopper JL, Houlston R, Hulick PJ, Hunter DJ, Huntsman DG, Idos G, Imyanitov EN, Ingles SA, Isaacs C, Jakubowska A, James P, Jenkins MA, Johansson M, Johansson M, John EM, Joshi AD, Kaneva R, Karlan BY, Kelemen LE, Kühl T, Khaw KT, Khusnutdinova E, Kibel AS, Kiemeney LA, Kim J, Kjaer SK, Knight JA, Kogevinas M, Kote-Jarai Z, Koutros S, Kristensen VN, Kupryjanczyk J, Lacko M, Lam S, Lambrechts D, Landi MT, Lazarus P, Le ND, Lee E, Lejbkowicz F, Lenz HJ, Leslie G, Lessel D, Lester J, Levine DA, Li L, Li CI, Lindblom A, Lindor NM, Liu G, Loupakis F, Lubiński J, Maehle L, Maier C, Mannermaa A, Marchand LL, Margolin S, May T, McGuffog L, Meindl A, Middha P, Miller A, Milne RL, MacInnis RJ, Modugno F, Montagna M, Moreno V, Moysich KB, Mucci L, Muir K, Mulligan AM, Nathanson KL, Neal DE, Ness AR, Neuhausen SL, Nevanlinna H, Newcomb PA, Newcomb LF, Nielsen FC, Nikitina-Zake L, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olama AAA, Olopade OI, Olshan AF, Olsson H, Osorio A, Pandha H, Park JY, Pashayan N, Parsons MT, Pejovic T, Penney KL, Peters WHM, Phelan CM, Phipps AI, Plaseska-Karanfilska D, Pring M, Prokofyeva D, Radice P, Stefansson K, Ramus SJ, Raskin L, Rennert G, Rennert HS, van Rensburg EJ, Riggan MJ, Risch HA, Risch A, Roobol MJ, Rosenstein BS, Rossing MA, De Ruyck K, Saloustros E, Sandler DP, Sawyer EJ, Schabath MB, Schleutker J, Schmidt MK, Setiawan VW, Shen H, Siegel EM, Sieh W, Singer CF, Slattery ML, Sorensen KD, Southey MC, Spurdle AB, Stanford JL, Stevens VL, Stintzing S, Stone J, Sundfeldt K, Sutphen R, Swerdlow AJ, Tajara EH, Tangen CM, Tardon A, Taylor JA, Teare MD, Teixeira MR, Terry MB, Terry KL, Thibodeau SN, Thomassen M, Bjørge L, Tischkowitz M, Toland AE, Torres D, Townsend PA, Travis RC, Tung N, Tworoger SS, Ulrich CM, Usmani N, Vachon CM, Van Nieuwenhuysen E, Vega A, Aguado-Barrera ME, Wang Q, Webb PM, Weinberg CR, Weinstein S, Weissler MC, Weitzel JN, West CML, White E, Whittemore AS, Wichmann HE, Wiklund F, Winqvist R, Wolk A, Woll P, Woods M, Wu AH, Wu X, Yannoukakos D, Zheng W, Zienolddiny S, Ziogas A, Zorn KK, Lane JM, Saxena R, Thomas D, Hung RJ, Diergaarde B, McKay J, Peters U, Hsu L, García-Closas M, Eeles RA, Chenevix-Trench G, Brennan PJ, Haiman CA, Simard J, Easton DF, Gruber SB, Pharoah PDP, Price AL, Pasaniuc B, Amos CI, Kraft P, Lindström S.

Nat Commun. 2019 Sep 23;10(1):4386. doi: 10.1038/s41467-019-12095-8.

7.

Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers.

Cole AP, Lu C, Krimphove MJ, Szymaniak J, Sun M, Fletcher SA, Lipsitz SR, Mahal BA, Nguyen PL, Choueiri TK, Kibel AS, Haider AH, Trinh QD.

J Natl Compr Canc Netw. 2019 Sep 1;17(9):1049-1058. doi: 10.6004/jnccn.2019.7296.

PMID:
31487683
8.

Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1 Renal Cell Carcinoma in Young and Healthy Individuals.

Tan WS, Berg S, Cole AP, Krimphove M, Marchese M, Lipsitz SR, Nabi J, Sammon JD, Choueiri TK, Kibel AS, Sun M, Chang S, Trinh QD.

JNCI Cancer Spectr. 2019 Feb 1;3(1):pkz003. doi: 10.1093/jncics/pkz003. eCollection 2019 Mar.

9.

Adverse Histopathologic Characteristics in Small Clear Cell Renal Cell Carcinomas Have Negative Impact on Prognosis: A Study of 631 Cases With Clinical Follow-up.

Yang C, Shuch B, Serrano M, Kibel AS, Nawaf C, Vollmer R, Humphrey PA, Adeniran AJ.

Am J Surg Pathol. 2019 Oct;43(10):1413-1420. doi: 10.1097/PAS.0000000000001333.

PMID:
31335354
10.

Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer.

Tan WS, Krimphove MJ, Cole AP, Marchese M, Berg S, Lipsitz SR, Löppenberg B, Nabi J, Abdollah F, Choueiri TK, Kibel AS, Sooriakumaran P, Trinh QD.

Clin Genitourin Cancer. 2019 Oct;17(5):e1060-e1068. doi: 10.1016/j.clgc.2019.06.008. Epub 2019 Jun 19.

PMID:
31303561
11.

Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?

Cole AP, Ramaswamy A, Harmouch S, Fletcher SA, Gild P, Sun M, Lipsitz SR, Chiang HA, Haider AH, Preston MA, Kibel AS, Trinh QD.

Eur Urol Oncol. 2019 Jul;2(4):349-354. doi: 10.1016/j.euo.2018.08.027. Epub 2018 Sep 25.

PMID:
31277772
12.

Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.

Gui B, Gui F, Takai T, Feng C, Bai X, Fazli L, Dong X, Liu S, Zhang X, Zhang W, Kibel AS, Jia L.

Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14573-14582. doi: 10.1073/pnas.1908547116. Epub 2019 Jul 2.

PMID:
31266892
13.

Contemporary national trends in prostate cancer risk profile at diagnosis.

Fletcher SA, von Landenberg N, Cole AP, Gild P, Choueiri TK, Lipsitz SR, Trinh QD, Kibel AS.

Prostate Cancer Prostatic Dis. 2019 Jun 24. doi: 10.1038/s41391-019-0157-y. [Epub ahead of print]

PMID:
31235801
14.

Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy.

Krimphove MJ, Szymaniak J, Marchese M, Tully KH, D'Andrea D, Mossanen M, Lipsitz SR, Kilbridge K, Kibel AS, Kluth LA, Shariat SF, Trinh QD.

Eur Urol Focus. 2019 Jun 18. pii: S2405-4569(19)30156-7. doi: 10.1016/j.euf.2019.06.001. [Epub ahead of print]

PMID:
31227463
15.

The association of marital status and mortality among men with early-stage prostate cancer treated with radical prostatectomy: insight into post-prostatectomy survival strategies.

Khan S, Nepple KG, Kibel AS, Sandhu G, Kallogjeri D, Strope S, Grubb R 3rd, Wolin KY, Sutcliffe S.

Cancer Causes Control. 2019 Aug;30(8):871-876. doi: 10.1007/s10552-019-01194-y. Epub 2019 Jun 18.

PMID:
31214808
16.

Comparison of Hospital Readmission After Total Hip and Total Knee Arthroplasty vs Spinal Surgery After Implementation of the Hospital Readmissions Reduction Program.

Ramaswamy A, Marchese M, Cole AP, Harmouch S, Friedlander D, Weissman JS, Lipsitz SR, Haider AH, Kibel AS, Schoenfeld AJ, Trinh QD.

JAMA Netw Open. 2019 May 3;2(5):e194634. doi: 10.1001/jamanetworkopen.2019.4634.

17.

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy.

Mossanen M, Nepple KG, Grubb RL 3rd, Androile GL, Kallogjeri D, Klein EA, Stephenson AJ, Kibel AS.

Eur Urol Oncol. 2018 Jun;1(2):143-148. doi: 10.1016/j.euo.2018.02.004. Epub 2018 May 15.

PMID:
31100238
18.

The current landscape of low-value care in men diagnosed with prostate cancer: what is the role of individual hospitals?

Krimphove MJ, Cole AP, Friedlander DF, Nguyen DD, Lipsitz SR, Nguyen PL, Kilbridge KL, Kibel AS, Kluth LA, Trinh QD.

Urol Oncol. 2019 Sep;37(9):575.e9-575.e18. doi: 10.1016/j.urolonc.2019.04.001. Epub 2019 May 2.

PMID:
31056436
19.

The bladder cancer conundrum: how do we treat the right tumour with the right treatment, at the right time?

Mossanen M, Kibel AS.

BJU Int. 2019 May;123(5):748-749. doi: 10.1111/bju.14688. No abstract available.

PMID:
31008564
20.

Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program.

Cole AP, Krasnova A, Ramaswamy A, Fletcher SA, Friedlander DF, McNabb-Baltar J, Melnitchouk N, Lipsitz SR, Sun M, Kibel AS, Golshan M, Haider AH, Weissman JS, Trinh QD.

J Oncol Pract. 2019 Jun;15(6):e547-e559. doi: 10.1200/JOP.18.00352. Epub 2019 Apr 18.

PMID:
30998420

Supplemental Content

Loading ...
Support Center